News

Celcuity Inc. Prepares for Second Quarter 2025 Financial Results

Celcuity Inc. Prepares for Second Quarter 2025 Financial Results

Upcoming Financial Release by Celcuity Inc.

Celcuity Inc. (Nasdaq: CELC), a promising clinical-stage biotechnology company, is eagerly preparing to unveil its financial results for the second quarter of 2025. The company has announced that this release will take place following the market's closing on a Thursday, with updates scheduled shortly thereafter. Management will engage with stakeholders via a live webcast and teleconference at 4:30 p.m. Eastern Time on the same day.

Webcast and Conference Participation Details

For those who wish to listen in on this insightful session, domestic participants can connect by calling 1-800-717-1738, while international callers are encouraged to dial 1-646-307-1865. The company will also stream the event live, allowing easy access for everyone interested in tracking Celcuity's latest developments and financial standing. A recording of this event will be made available on the company's website shortly after.

About Celcuity Inc.

Celcuity is dedicated to developing innovative targeted therapies aimed at treating a variety of solid tumors. Central to its mission is gedatolisib, a groundbreaking, potent pan-PI3K and mTORC1/2 inhibitor that effectively disrupts the PAM pathway. Its unique mechanism of action differentiates it significantly from other treatments that target PI3K?, AKT, or mTORC1 either in isolation or combination. This innovative approach could markedly improve patient outcomes in oncology.

Ongoing Clinical Trials

The company is currently conducting critical Phase 3 and Phase 1/2 clinical trials to evaluate gedatolisib's efficacy in various treatment settings. One notable trial, VIKTORIA-1, assesses gedatolisib in combination with fulvestrant, with or without palbociclib, for patients suffering from HR+/HER2- advanced breast cancer. This pivotal study is currently enrolling participants, indicating the strong commitment of Celcuity to advancing cancer treatments.

Another significant study, CELC-G-201, explores the combination of gedatolisib and darolutamide in patients diagnosed with metastatic castration-resistant prostate cancer. Similarly, VIKTORIA-2 is a reputable Phase 3 trial looking at gedatolisib combined with a CDK4/6 inhibitor alongside fulvestrant as a first-line treatment for HR+/HER2- late-stage breast cancer. Both studies demonstrate Celcuity's strategic focus on targeted therapy development for difficult-to-treat conditions.

More Information About Celcuity

Celcuity is headquartered in Minneapolis, where it continues to foster innovation in its clinical pursuits. For anyone interested in learning more about their active trials and corporate initiatives, detailed information can be accessed through the company's official website, where additional resources and updates can be found.

Company Contacts

For further inquiries, stakeholders may contact Brian Sullivan at bsullivan@celcuity.com or Vicky Hahne at vhahne@celcuity.com. They can also be reached through the phone number (763) 392-0123.

Additionally, those wishing to communicate through ICR Healthcare can reach out to Patti Bank at patti.bank@icrhealthcare.com, or by calling (415) 513-1284.

Frequently Asked Questions

What is the purpose of Celcuity’s upcoming conference call?

The call is designed to discuss the company’s financial results for Q2 2025 and to provide updates on its clinical programs.

How can I participate in the conference call?

Participants can join by dialing the specified domestic and international phone numbers, or by accessing the live webcast available on the company's website.

What is gedatolisib and why is it significant?

Gedatolisib is Celcuity's lead therapeutic candidate, noted for its unique approach in inhibiting the PAM pathway, which may improve treatment responses compared to existing therapies.

What clinical trials is Celcuity currently conducting?

Celcuity is conducting several pivotal studies, including VIKTORIA-1 and CELC-G-201, focusing on breast cancer and prostate cancer therapies, respectively.

Where can I find more information about Celcuity?

Detailed information and updates regarding Celcuity and its clinical trials are available on the company’s official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 47

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
IEHP's Wellness Center Launch Faces Delay in California

Updated Category News Views 99

Unexpected Delay for IEHP's Community Hub Straight outta Rancho Cucamonga, we've got some news that'll have folks in San Bernardino holding their breath a little longer. The Inland Empire Health Plan (or IEHP if you're part of the 1.4 million served by them) had folks pumped for their new Community Wellness Center. But guess what? They had to slam the brakes on the grand...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 132

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 111

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 136

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 183

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
PenFed Fuels Aggie Spirit with Blackout Game Activation

Updated Category News Views 196

A Different Kind of Game Day Experience Ah, there's nothing quite like the vibrancy of a Texas A&M game day, especially when it's a blackout event. On November 14, fans aren't just getting the good old college football thrills; they're diving headfirst into an extravaganza, courtesy of PenFed Credit Union. You might know them as the go-to credit union for military folks,...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 115

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading
GTEC Faces Nasdaq Bid Price Compliance Challenge

Updated Category News Views 228

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 140

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

Hedonia Partners with Quantify to Transform Mental Health Access

Updated Category News Views 277

Introducing a Game-Changing Partnership for Mental Health Hedonia and Quantify Remote Care have embarked on a collaborative journey to reshape the mental health landscape. This strategic alliance focuses on bringing Revolutionary digital therapeutic solutions to patients, allowing them to access quality mental health care more than ever before. By marrying innovative...

Continue Reading
Savara Inc. Faces Legal Challenges: What Investors Should Know

Updated Category News Views 137

Understanding the Recent Legal Issues Surrounding Savara Inc. Investors are paying close attention to the unfolding situation regarding Savara Inc. (NASDAQ: SVRA), as the company faces a class action lawsuit linked to securities law violations. This case has raised many questions about the company's integrity and the implications for shareholders. What Sparked the...

Continue Reading
Understanding the Shift in Investor Sentiment for JLL Stock

Updated Category News Views 139

Analyzing Investor Sentiment for Jones Lang LaSalle Jones Lang LaSalle's (JLL) stock has seen some interesting trends recently. Notably, the short percent of float has decreased by 31.32% since the last reporting period, indicating a significant shift in how traders are positioning themselves with respect to the stock. Currently, there are approximately 775 thousand...

Continue Reading
Definity Financial's Q2 2025 Performance Highlights and Outlook

Updated Category News Views 250

Definity Financial Corporation Releases Q2 2025 Results Definity Financial Corporation (TSX: DFY) has recently unveiled its results for the second quarter of 2025, demonstrating a solid financial performance backed by strategic initiatives and a focus on growth. Financial Highlights This quarter showcased a growth of 9.1% in gross written premiums excluding exited lines,...

Continue Reading
Exciting News: FiRE + iCE Opens New Location on Pier 39

Updated Category News Views 236

FiRE + iCE Unveils New Interactive Bar and Grill Location FiRE + iCE, known for its engaging all-you-can-eat dining, is thrilled to announce the opening of its new location at the iconic Pier 39, bringing a unique culinary experience to the vibrant food scene. Crafting a Unique Dining Experience The interactive grill encourages diners to unleash their creativity as they...

Continue Reading